Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C virus seropositivity. Findings suggest parenteral acquisition of some PARV4 infections.

Original publication

DOI

10.3201/eid1804.110628

Type

Journal article

Journal

Emerging infectious diseases

Publication Date

04/2012

Volume

18

Pages

680 - 683

Addresses

Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Keywords

Humans, Parvovirus, Parvoviridae Infections, Hepatitis C, Injections, Prevalence, Multivariate Analysis, Logistic Models, Cohort Studies, Seroepidemiologic Studies, Aged, Aged, 80 and over, Middle Aged, Cameroon, Female, Male, Coinfection